MAGEA3 and hepatocellular carcinoma: We have developed a nested RT–PCR assay to detect MAGE-1 and MAGE-3 transcripts in PBMC, through which to evaluate them as the early markers to unveil hematogeneous dissemination of HCC cells and their potential clinical implications.